> top > docs > PMC:3359311 > spans > 10426-12381 > annotations

PMC:3359311 / 10426-12381 JSONTXT

Annnotations TAB JSON ListView MergeView

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T3907 59-64 P01584 denotes IL-1β
T3908 536-541 P01584 denotes IL-1β
T3909 555-559 P10145 denotes IL-8
T3910 676-681 P01584 denotes IL-1β
T3911 806-810 P26993 denotes exsA
T3912 888-893 P01584 denotes IL-1β
T3913 1017-1022 P01584 denotes IL-1β
T3914 1183-1188 P01584 denotes IL-1β
T3915 1192-1196 P10145 denotes IL-8
T13748 1526-1531 P01584 denotes IL-1β
T13749 1720-1724 P26993 denotes exsA
T13750 1809-1813 P26993 denotes exsA
T13751 1933-1938 P01584 denotes IL-1β
T13752 1947-1951 P10145 denotes IL-8

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue Negation
T3606 30-37 Gene_expression denotes produce
T3607 38-47 Positive_regulation denotes increased true
T3608 59-64 Protein denotes IL-1β
T3609 507-514 Gene_expression denotes produce
T3610 515-524 Positive_regulation denotes increased true
T3611 536-541 Protein denotes IL-1β
T3612 640-648 Negative_regulation denotes decrease
T3613 676-681 Protein denotes IL-1β
T3614 682-690 Gene_expression denotes produced
T3615 703-717 Positive_regulation denotes in response to
T3616 806-810 Protein denotes exsA
T3617 863-871 Gene_expression denotes produced
T3618 883-887 Negative_regulation denotes less
T3619 888-893 Protein denotes IL-1β
T3620 1003-1009 Positive_regulation denotes result true
T3621 1017-1022 Protein denotes IL-1β
T3622 1023-1033 Gene_expression denotes production true
T3623 1159-1168 Positive_regulation denotes increased true
T3624 1159-1168 Positive_regulation denotes increased true
T3625 1169-1179 Gene_expression denotes production
T3626 1169-1179 Gene_expression denotes production
T3627 1183-1188 Protein denotes IL-1β
T3628 1192-1196 Protein denotes IL-8
T13633 1497-1504 Gene_expression denotes produce
T13634 1505-1514 Positive_regulation denotes increased true
T13635 1526-1531 Protein denotes IL-1β
T13636 1712-1719 Negative_regulation denotes lacking
T13637 1720-1724 Protein denotes exsA
T13638 1801-1808 Negative_regulation denotes lacking
T13639 1809-1813 Protein denotes exsA
T13640 1933-1938 Protein denotes IL-1β
R3115 T3606 T3607 themeOf produce,increased
R3116 T3608 T3606 themeOf IL-1β,produce
R3117 T3609 T3610 themeOf produce,increased
R3118 T3611 T3609 themeOf IL-1β,produce
R3119 T3612 T3615 themeOf decrease,in response to
R3120 T3613 T3614 themeOf IL-1β,produced
R3121 T3614 T3612 themeOf produced,decrease
R3122 T3617 T3618 themeOf produced,less
R3123 T3619 T3617 themeOf IL-1β,produced
R3124 T3621 T3622 themeOf IL-1β,production
R3125 T3622 T3620 themeOf production,result
R3126 T3625 T3623 themeOf production,increased
R3127 T3626 T3624 themeOf production,increased
R3128 T3627 T3625 themeOf IL-1β,production
R3129 T3628 T3626 themeOf IL-8,production
R12100 T13633 T13634 themeOf produce,increased
R12101 T13635 T13633 themeOf IL-1β,produce
R12102 T13637 T13636 themeOf exsA,lacking
R12103 T13639 T13638 themeOf exsA,lacking

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T4279 59-64 Protein denotes IL-1β
T4280 30-37 Gene_expression denotes produce
T4281 38-47 Positive_regulation denotes increased
T4282 166-171 Protein denotes NF-κB
T4283 156-165 Positive_regulation denotes increased
T4284 211-220 Localization denotes secretion
T4285 156-165 Positive_regulation denotes increased
T4286 358-362 Protein denotes PAO1
T4287 410-415 Protein denotes NLRC4
T4288 417-422 Protein denotes NLRP3
T4289 397-405 Positive_regulation denotes activate
T4290 397-405 Positive_regulation denotes activate
T4291 536-541 Protein denotes IL-1β
T4292 543-550 Protein denotes Fig. 5a
T4293 555-559 Protein denotes IL-8
T4294 561-568 Protein denotes Fig. 5b
T4295 507-514 Gene_expression denotes produce
T4296 507-514 Gene_expression denotes produce
T4297 507-514 Gene_expression denotes produce
T4298 507-514 Gene_expression denotes produce
T4299 515-524 Positive_regulation denotes increased
T4300 515-524 Positive_regulation denotes increased
T4301 515-524 Positive_regulation denotes increased
T4302 515-524 Positive_regulation denotes increased
T4303 676-681 Protein denotes IL-1β
T4304 682-690 Gene_expression denotes produced
T4305 806-810 Protein denotes exsA
T4306 812-821 Protein denotes PAO1ΔexsA
T4307 888-893 Protein denotes IL-1β
T4308 919-923 Protein denotes PAO1
T4309 800-805 Negative_regulation denotes lacks
T4310 800-805 Negative_regulation denotes lacks
T4311 863-871 Gene_expression denotes produced
T4312 1017-1022 Protein denotes IL-1β
T4313 1023-1033 Gene_expression denotes production
T4314 1003-1009 Positive_regulation denotes result
T4315 1183-1188 Protein denotes IL-1β
T4316 1192-1196 Protein denotes IL-8
T4317 1277-1282 Protein denotes NF-κB
T4318 1169-1179 Gene_expression denotes production
T4319 1169-1179 Gene_expression denotes production
T4320 1159-1168 Positive_regulation denotes increased
T4321 1159-1168 Positive_regulation denotes increased
T4322 1348-1357 Protein denotes caspase-1
T13902 1526-1531 Protein denotes IL-1β
T13903 1497-1504 Gene_expression denotes produce
T13904 1505-1514 Positive_regulation denotes increased
T13905 1696-1711 Protein denotes aeruginosa PAO1
T13906 1720-1724 Protein denotes exsA
T13907 1712-1719 Negative_regulation denotes lacking
T13908 1712-1719 Negative_regulation denotes lacking
T13909 1809-1813 Protein denotes exsA
T13910 1801-1808 Negative_regulation denotes lacking
R3727 T4279 T4280 themeOf IL-1β,produce
R3728 T4279 T4281 themeOf IL-1β,increased
R3729 T4282 T4283 themeOf NF-κB,increased
R3730 T4282 T4284 themeOf NF-κB,secretion
R3731 T4284 T4285 themeOf secretion,increased
R3732 T4287 T4289 themeOf NLRC4,activate
R3733 T4288 T4290 themeOf NLRP3,activate
R3734 T4291 T4295 themeOf IL-1β,produce
R3735 T4291 T4299 themeOf IL-1β,increased
R3736 T4292 T4296 themeOf Fig. 5a,produce
R3737 T4292 T4300 themeOf Fig. 5a,increased
R3738 T4293 T4297 themeOf IL-8,produce
R3739 T4293 T4301 themeOf IL-8,increased
R3740 T4294 T4298 themeOf Fig. 5b,produce
R3741 T4294 T4302 themeOf Fig. 5b,increased
R3742 T4303 T4304 themeOf IL-1β,produced
R3743 T4305 T4309 themeOf exsA,lacks
R3744 T4306 T4310 themeOf PAO1ΔexsA,lacks
R3745 T4307 T4311 themeOf IL-1β,produced
R3746 T4312 T4313 themeOf IL-1β,production
R3747 T4313 T4314 themeOf production,result
R3748 T4315 T4318 themeOf IL-1β,production
R3749 T4316 T4319 themeOf IL-8,production
R3750 T4318 T4320 themeOf production,increased
R3751 T4319 T4321 themeOf production,increased
R12339 T13902 T13903 themeOf IL-1β,produce
R12340 T13902 T13904 themeOf IL-1β,increased
R12341 T13905 T13907 themeOf aeruginosa PAO1,lacking
R12342 T13906 T13908 themeOf exsA,lacking
R12343 T13909 T13910 themeOf exsA,lacking

events-check-again

Id Subject Object Predicate Lexical cue Negation
T4256 30-37 Gene_expression denotes produce
T4257 38-47 Positive_regulation denotes increased true
T4258 59-64 Protein denotes IL-1β
T4259 507-514 Gene_expression denotes produce
T4260 515-524 Positive_regulation denotes increased true
T4261 536-541 Protein denotes IL-1β
T4262 640-648 Negative_regulation denotes decrease
T4263 676-681 Protein denotes IL-1β
T4264 682-690 Gene_expression denotes produced
T4265 703-717 Positive_regulation denotes in response to
T4266 806-810 Protein denotes exsA
T4267 863-871 Gene_expression denotes produced
T4268 883-887 Negative_regulation denotes less
T4269 888-893 Protein denotes IL-1β
T4270 1003-1009 Positive_regulation denotes result true
T4271 1017-1022 Protein denotes IL-1β
T4272 1023-1033 Gene_expression denotes production true
T4273 1159-1168 Positive_regulation denotes increased true
T4274 1159-1168 Positive_regulation denotes increased true
T4275 1169-1179 Gene_expression denotes production
T4276 1169-1179 Gene_expression denotes production
T4277 1183-1188 Protein denotes IL-1β
T4278 1192-1196 Protein denotes IL-8
T13894 1497-1504 Gene_expression denotes produce
T13895 1505-1514 Positive_regulation denotes increased true
T13896 1526-1531 Protein denotes IL-1β
T13897 1712-1719 Negative_regulation denotes lacking
T13898 1720-1724 Protein denotes exsA
T13899 1801-1808 Negative_regulation denotes lacking
T13900 1809-1813 Protein denotes exsA
T13901 1933-1938 Protein denotes IL-1β
R3712 T4256 T4257 themeOf produce,increased
R3713 T4258 T4256 themeOf IL-1β,produce
R3714 T4259 T4260 themeOf produce,increased
R3715 T4261 T4259 themeOf IL-1β,produce
R3716 T4262 T4265 themeOf decrease,in response to
R3717 T4263 T4264 themeOf IL-1β,produced
R3718 T4264 T4262 themeOf produced,decrease
R3719 T4267 T4268 themeOf produced,less
R3720 T4269 T4267 themeOf IL-1β,produced
R3721 T4271 T4272 themeOf IL-1β,production
R3722 T4272 T4270 themeOf production,result
R3723 T4275 T4273 themeOf production,increased
R3724 T4276 T4274 themeOf production,increased
R3725 T4277 T4275 themeOf IL-1β,production
R3726 T4278 T4276 themeOf IL-8,production
R12335 T13894 T13895 themeOf produce,increased
R12336 T13896 T13894 themeOf IL-1β,produce
R12337 T13898 T13897 themeOf exsA,lacking
R12338 T13900 T13899 themeOf exsA,lacking

GO-CC

Id Subject Object Predicate Lexical cue
T4207 697-702 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

GO-MF

Id Subject Object Predicate Lexical cue
T4208 555-559 http://purl.obolibrary.org/obo/GO_0005153 denotes IL-8
T4209 1192-1196 http://purl.obolibrary.org/obo/GO_0005153 denotes IL-8
T13877 1947-1951 http://purl.obolibrary.org/obo/GO_0005153 denotes IL-8

GO-BP

Id Subject Object Predicate Lexical cue
T4203 202-220 http://purl.obolibrary.org/obo/GO_0050663 denotes cytokine secretion
T4204 211-220 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T4205 852-861 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T4206 706-721 http://purl.obolibrary.org/obo/GO_0032496 denotes response to LPS
T13876 1837-1846 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T3916 0-5 NNS denotes PBMCs
T3917 6-10 IN denotes from
T3918 11-13 NNP denotes CF
T3919 14-22 NNS denotes patients
T3920 23-25 VBP denotes do
T3921 26-29 RB denotes not
T3922 30-37 VB denotes produce
T3923 38-47 JJ denotes increased
T3924 48-55 NNS denotes amounts
T3925 56-58 IN denotes of
T3926 59-64 NN denotes IL-1β
T3927 65-69 IN denotes upon
T3928 70-82 JJ denotes inflammasome
T3929 83-94 NN denotes stimulation
T3930 95-103 JJ denotes Previous
T3931 104-111 NNS denotes studies
T3932 112-116 VBP denotes have
T3933 117-122 VBN denotes shown
T3934 123-127 IN denotes that
T3935 128-131 DT denotes the
T3936 132-136 NN denotes loss
T3937 137-139 IN denotes of
T3938 140-144 NNP denotes CFTR
T3939 145-152 NNS denotes results
T3940 153-155 IN denotes in
T3941 156-165 VBN denotes increased
T3942 166-171 NN denotes NF-κB
T3943 172-180 NN denotes activity
T3944 181-184 CC denotes and
T3945 185-201 JJ denotes pro-inflammatory
T3946 202-210 NN denotes cytokine
T3947 211-220 NN denotes secretion
T3948 221-222 NNP denotes [
T3949 222-223 CD denotes 4
T3950 223-224 NNP denotes ]
T3951 224-225 , denotes ,
T3952 226-227 NNP denotes [
T3953 227-228 CD denotes 5
T3954 228-229 NNP denotes ]
T3955 229-230 , denotes ,
T3956 231-232 NNP denotes [
T3957 232-234 CD denotes 32
T3958 234-235 NNP denotes ]
T3959 235-236 , denotes ,
T3960 237-238 NNP denotes [
T3961 238-240 CD denotes 36
T3962 240-241 NNP denotes ]
T3963 241-242 , denotes ,
T3964 243-244 NNP denotes [
T3965 244-246 CD denotes 37
T3966 246-247 NNP denotes ]
T3967 247-248 . denotes .
T3968 249-251 TO denotes To
T3969 252-259 RBR denotes further
T3970 260-267 VB denotes examine
T3971 268-272 DT denotes this
T3972 273-285 NN denotes relationship
T3973 285-286 , denotes ,
T3974 287-292 NNP denotes PBMCs
T3975 293-297 IN denotes from
T3976 298-300 NNP denotes CF
T3977 301-309 NNS denotes patients
T3978 310-313 CC denotes and
T3979 314-321 JJ denotes healthy
T3980 322-327 NN denotes adult
T3981 328-336 NNS denotes controls
T3982 337-341 VBD denotes were
T3983 342-352 VBN denotes stimulated
T3984 353-357 IN denotes with
T3985 358-362 NNP denotes PAO1
T3986 362-363 , denotes ,
T3987 364-371 NNP denotes LPS+ATP
T3988 371-372 , denotes ,
T3989 373-376 CC denotes and
T3990 377-382 NNP denotes LPS+P
T3991 382-385 NN denotes oly
T3992 385-386 -LRB- denotes (
T3993 386-388 NN denotes dA
T3994 388-389 : denotes :
T3995 389-391 NN denotes dT
T3996 391-392 -RRB- denotes )
T3997 392-393 , denotes ,
T3998 394-396 TO denotes to
T3999 397-405 VB denotes activate
T4000 406-409 DT denotes the
T4001 410-415 NNP denotes NLRC4
T4002 415-416 , denotes ,
T4003 417-422 NNP denotes NLRP3
T4004 422-423 , denotes ,
T4005 424-427 CC denotes and
T4006 428-432 NNP denotes AIM2
T4007 433-446 NNS denotes inflammasomes
T4008 446-447 , denotes ,
T4009 448-460 RB denotes respectively
T4010 460-461 . denotes .
T4011 462-464 IN denotes By
T4012 465-467 CD denotes 24
T4013 468-473 NNS denotes hours
T4014 474-476 IN denotes of
T4015 477-488 NN denotes stimulation
T4016 488-489 , denotes ,
T4017 490-492 NNP denotes CF
T4018 493-498 NNP denotes PBMCs
T4019 499-502 VBD denotes did
T4020 503-506 RB denotes not
T4021 507-514 VB denotes produce
T4022 515-524 JJ denotes increased
T4023 525-532 NNS denotes amounts
T4024 533-535 IN denotes of
T4025 536-541 NN denotes IL-1β
T4026 542-543 -LRB- denotes (
T4027 543-547 NNP denotes Fig.
T4028 548-550 CD denotes 5a
T4029 550-551 -RRB- denotes )
T4030 552-554 CC denotes or
T4031 555-559 NN denotes IL-8
T4032 560-561 -LRB- denotes (
T4033 561-565 NNP denotes Fig.
T4034 566-568 CD denotes 5b
T4035 568-569 -RRB- denotes )
T4036 570-574 WRB denotes when
T4037 575-583 VBN denotes compared
T4038 584-586 TO denotes to
T4039 587-594 JJ denotes healthy
T4040 595-603 NNS denotes controls
T4041 603-604 . denotes .
T4042 605-612 RB denotes However
T4043 612-613 , denotes ,
T4044 614-616 PRP denotes we
T4045 617-620 VBD denotes did
T4046 621-627 VB denotes notice
T4047 628-629 DT denotes a
T4048 630-639 NN denotes transient
T4049 640-648 NN denotes decrease
T4050 649-650 -LRB- denotes (
T4051 650-651 NNP denotes P
T4052 651-652 CD denotes <
T4053 652-657 CD denotes 0.001
T4054 657-658 -RRB- denotes )
T4055 659-661 IN denotes in
T4056 662-665 DT denotes the
T4057 666-672 NN denotes amount
T4058 673-675 IN denotes of
T4059 676-681 JJ denotes IL-1β
T4060 682-690 VBN denotes produced
T4061 691-693 IN denotes by
T4062 694-696 NNP denotes CF
T4063 697-702 NNS denotes cells
T4064 703-705 IN denotes in
T4065 706-714 NN denotes response
T4066 715-717 TO denotes to
T4067 718-725 NNP denotes LPS+ATP
T4068 726-728 IN denotes at
T4069 729-730 CD denotes 6
T4070 731-736 NNS denotes hours
T4071 737-738 -LRB- denotes (
T4072 738-742 NNS denotes data
T4073 743-746 RB denotes not
T4074 747-752 VBN denotes shown
T4075 752-753 -RRB- denotes )
T4076 753-754 . denotes .
T4077 755-766 NN denotes Stimulation
T4078 767-769 IN denotes of
T4079 770-775 NNS denotes PBMCs
T4080 776-780 IN denotes with
T4081 781-783 NNP denotes P.
T4082 784-794 NN denotes aeruginosa
T4083 795-799 WDT denotes that
T4084 800-805 VBZ denotes lacks
T4085 806-810 NNP denotes exsA
T4086 811-812 -LRB- denotes (
T4087 812-821 NNP denotes PAO1ΔexsA
T4088 821-822 -RRB- denotes )
T4089 822-823 , denotes ,
T4090 824-825 DT denotes a
T4091 826-829 JJ denotes key
T4092 830-839 NN denotes regulator
T4093 840-842 IN denotes of
T4094 843-847 NN denotes type
T4095 848-851 NNP denotes III
T4096 852-861 NN denotes secretion
T4097 861-862 , denotes ,
T4098 863-871 VBD denotes produced
T4099 872-882 JJ denotes three-fold
T4100 883-887 RBR denotes less
T4101 888-893 JJ denotes IL-1β
T4102 894-902 VBN denotes compared
T4103 903-905 TO denotes to
T4104 906-909 DT denotes the
T4105 910-918 JJ denotes parental
T4106 919-923 NNP denotes PAO1
T4107 924-930 NN denotes strain
T4108 931-933 IN denotes by
T4109 934-936 CD denotes 24
T4110 937-942 NNS denotes hours
T4111 943-944 -LRB- denotes (
T4112 944-948 NNP denotes Fig.
T4113 949-951 CD denotes 5a
T4114 951-952 -RRB- denotes )
T4115 952-953 . denotes .
T4116 954-966 JJ denotes Inflammasome
T4117 967-978 NN denotes stimulation
T4118 979-986 IN denotes without
T4119 987-994 VBG denotes priming
T4120 995-998 VBD denotes did
T4121 999-1002 RB denotes not
T4122 1003-1009 VB denotes result
T4123 1010-1012 IN denotes in
T4124 1013-1016 DT denotes any
T4125 1017-1022 JJ denotes IL-1β
T4126 1023-1033 NN denotes production
T4127 1034-1036 IN denotes in
T4128 1037-1043 CC denotes either
T4129 1044-1046 NNP denotes CF
T4130 1047-1049 CC denotes or
T4131 1050-1057 NN denotes control
T4132 1058-1063 NNS denotes PBMCs
T4133 1063-1064 . denotes .
T4134 1065-1073 JJ denotes Contrary
T4135 1074-1076 TO denotes to
T4136 1077-1080 PRP$ denotes our
T4137 1081-1091 NN denotes hypothesis
T4138 1091-1092 , denotes ,
T4139 1093-1098 DT denotes these
T4140 1099-1106 NNS denotes results
T4141 1107-1115 VBP denotes indicate
T4142 1116-1120 IN denotes that
T4143 1121-1126 NNS denotes PBMCs
T4144 1127-1131 IN denotes from
T4145 1132-1134 NNP denotes CF
T4146 1135-1143 NNS denotes patients
T4147 1144-1146 VBP denotes do
T4148 1147-1150 RB denotes not
T4149 1151-1158 VB denotes display
T4150 1159-1168 VBN denotes increased
T4151 1169-1179 NN denotes production
T4152 1180-1182 IN denotes of
T4153 1183-1188 NN denotes IL-1β
T4154 1189-1191 CC denotes or
T4155 1192-1196 NN denotes IL-8
T4156 1197-1201 IN denotes with
T4157 1202-1214 JJ denotes inflammasome
T4158 1215-1225 NN denotes activation
T4159 1226-1229 CC denotes nor
T4160 1230-1232 VBP denotes do
T4161 1233-1237 PRP denotes they
T4162 1238-1245 VBP denotes suggest
T4163 1246-1249 DT denotes any
T4164 1250-1259 VBN denotes increased
T4165 1260-1265 NN denotes basal
T4166 1266-1268 CC denotes or
T4167 1269-1276 JJ denotes induced
T4168 1277-1282 NN denotes NF-κB
T4169 1283-1291 NN denotes activity
T4170 1291-1292 . denotes .
T4171 1293-1298 DT denotes These
T4172 1299-1306 NNS denotes results
T4173 1307-1310 VBP denotes are
T4174 1311-1321 JJ denotes consistent
T4175 1322-1326 IN denotes with
T4176 1327-1330 PRP$ denotes our
T4177 1331-1342 NN denotes observation
T4178 1343-1347 IN denotes that
T4179 1348-1357 JJ denotes caspase-1
T4180 1358-1366 NN denotes activity
T4181 1367-1369 VBZ denotes is
T4182 1370-1373 RB denotes not
T4183 1374-1383 JJ denotes different
T4184 1384-1391 IN denotes between
T4185 1392-1394 NNP denotes CF
T4186 1395-1398 CC denotes and
T4187 1399-1406 VB denotes control
T4188 1407-1412 NNP denotes PBMCs
T4189 1413-1414 -LRB- denotes (
T4190 1414-1418 NNP denotes Fig.
T4191 1419-1420 CD denotes 4
T4192 1420-1421 -RRB- denotes )
T4193 1421-1422 . denotes .
T13753 1467-1472 NNS denotes PBMCs
T13754 1473-1477 IN denotes from
T13755 1478-1480 NNP denotes CF
T13756 1481-1489 NNS denotes patients
T13757 1490-1492 VBP denotes do
T13758 1493-1496 RB denotes not
T13759 1497-1504 VB denotes produce
T13760 1505-1514 JJ denotes increased
T13761 1515-1522 NNS denotes amounts
T13762 1523-1525 IN denotes of
T13763 1526-1531 NN denotes IL-1β
T13764 1531-1532 . denotes .
T13765 1533-1538 NNS denotes PBMCs
T13766 1539-1543 IN denotes from
T13767 1544-1546 NNP denotes CF
T13768 1547-1555 NNS denotes patients
T13769 1556-1557 -LRB- denotes (
T13770 1557-1558 FW denotes n
T13771 1559-1560 SYM denotes =
T13772 1561-1563 CD denotes 17
T13773 1564-1566 CD denotes 20
T13774 1566-1567 -RRB- denotes )
T13775 1568-1571 CC denotes and
T13776 1572-1579 JJ denotes healthy
T13777 1580-1588 NNS denotes controls
T13778 1589-1590 -LRB- denotes (
T13779 1590-1591 FW denotes n
T13780 1592-1593 SYM denotes =
T13781 1594-1596 CD denotes 15
T13782 1597-1599 CD denotes 19
T13783 1599-1600 -RRB- denotes )
T13784 1601-1605 VBD denotes were
T13785 1606-1612 VBN denotes primed
T13786 1613-1617 IN denotes with
T13787 1618-1621 NNP denotes LPS
T13788 1622-1623 -LRB- denotes (
T13789 1623-1625 CD denotes 10
T13790 1626-1631 NN denotes ng/ml
T13791 1631-1632 -RRB- denotes )
T13792 1633-1642 JJ denotes overnight
T13793 1643-1646 CC denotes and
T13794 1647-1657 VBN denotes stimulated
T13795 1658-1662 IN denotes with
T13796 1663-1665 NNP denotes P.
T13797 1666-1676 NN denotes aeruginosa
T13798 1677-1681 NNP denotes PAO1
T13799 1682-1683 -LRB- denotes (
T13800 1683-1686 NNP denotes MOI
T13801 1687-1688 SYM denotes =
T13802 1689-1690 LS denotes 1
T13803 1690-1691 -RRB- denotes )
T13804 1691-1692 , denotes ,
T13805 1693-1695 NNP denotes P.
T13806 1696-1706 NNP denotes aeruginosa
T13807 1707-1711 NNP denotes PAO1
T13808 1712-1719 VBG denotes lacking
T13809 1720-1724 NNP denotes exsA
T13810 1725-1726 -LRB- denotes (
T13811 1726-1729 NNP denotes MOI
T13812 1730-1731 SYM denotes =
T13813 1732-1733 LS denotes 1
T13814 1733-1734 -RRB- denotes )
T13815 1734-1735 , denotes ,
T13816 1736-1739 NNP denotes ATP
T13817 1740-1741 -LRB- denotes (
T13818 1741-1742 CD denotes 5
T13819 1743-1745 NNP denotes mM
T13820 1745-1746 -RRB- denotes )
T13821 1746-1747 , denotes ,
T13822 1748-1750 CC denotes or
T13823 1751-1755 NNP denotes Poly
T13824 1755-1756 -LRB- denotes (
T13825 1756-1758 NNP denotes dA
T13826 1758-1759 : denotes :
T13827 1759-1761 NN denotes dT
T13828 1761-1762 -RRB- denotes )
T13829 1763-1764 -LRB- denotes (
T13830 1764-1765 CD denotes 1
T13831 1766-1768 NN denotes µg
T13832 1768-1769 NN denotes /
T13833 1769-1771 NN denotes ml
T13834 1771-1772 -RRB- denotes )
T13835 1773-1776 IN denotes for
T13836 1777-1779 CD denotes 24
T13837 1780-1785 NNS denotes hours
T13838 1785-1786 . denotes .
T13839 1787-1789 NNP denotes P.
T13840 1790-1800 NN denotes aeruginosa
T13841 1801-1808 VBG denotes lacking
T13842 1809-1813 NNP denotes exsA
T13843 1814-1817 VBD denotes was
T13844 1818-1822 VBN denotes used
T13845 1823-1825 IN denotes as
T13846 1826-1827 DT denotes a
T13847 1828-1832 NN denotes type
T13848 1833-1836 NNP denotes III
T13849 1837-1846 NN denotes secretion
T13850 1847-1854 NN denotes control
T13851 1855-1857 IN denotes in
T13852 1858-1868 NN denotes comparison
T13853 1869-1873 IN denotes with
T13854 1874-1883 JJ denotes wild-type
T13855 1884-1886 NNP denotes P.
T13856 1887-1897 NN denotes aeruginosa
T13857 1897-1898 . denotes .
T13858 1899-1911 NNS denotes Supernatants
T13859 1912-1916 VBD denotes were
T13860 1917-1924 VBN denotes assayed
T13861 1925-1928 IN denotes for
T13862 1929-1930 -LRB- denotes (
T13863 1930-1931 NN denotes A
T13864 1931-1932 -RRB- denotes )
T13865 1933-1938 NN denotes IL-1β
T13866 1939-1942 CC denotes and
T13867 1943-1944 -LRB- denotes (
T13868 1944-1945 NNP denotes B
T13869 1945-1946 -RRB- denotes )
T13870 1947-1951 NN denotes IL-8
T13871 1951-1952 . denotes .
R3404 T3916 T3922 nsubj PBMCs,produce
R3405 T3917 T3916 prep from,PBMCs
R3406 T3918 T3919 compound CF,patients
R3407 T3919 T3917 pobj patients,from
R3408 T3920 T3922 aux do,produce
R3409 T3921 T3922 neg not,produce
R3410 T3922 T3922 ROOT produce,produce
R3411 T3923 T3924 amod increased,amounts
R3412 T3924 T3922 dobj amounts,produce
R3413 T3925 T3924 prep of,amounts
R3414 T3926 T3925 pobj IL-1β,of
R3415 T3927 T3922 prep upon,produce
R3416 T3928 T3929 amod inflammasome,stimulation
R3417 T3929 T3931 nmod stimulation,studies
R3418 T3930 T3931 amod Previous,studies
R3419 T3931 T3927 pobj studies,upon
R3420 T3932 T3933 aux have,shown
R3421 T3933 T3922 conj shown,produce
R3422 T3934 T3933 dobj that,shown
R3423 T3935 T3936 det the,loss
R3424 T3936 T3934 nsubj loss,that
R3425 T3937 T3936 prep of,loss
R3426 T3938 T3939 compound CFTR,results
R3427 T3939 T3937 pobj results,of
R3428 T3940 T3939 prep in,results
R3429 T3941 T3943 amod increased,activity
R3430 T3942 T3943 compound NF-κB,activity
R3431 T3943 T3940 pobj activity,in
R3432 T3944 T3943 cc and,activity
R3433 T3945 T3947 amod pro-inflammatory,secretion
R3434 T3946 T3947 compound cytokine,secretion
R3435 T3947 T3943 conj secretion,activity
R3436 T3948 T3950 nmod [,]
R3437 T3949 T3950 nummod 4,]
R3438 T3950 T3947 nmod ],secretion
R3439 T3951 T3950 punct ",",]
R3440 T3952 T3954 nmod [,]
R3441 T3953 T3954 nummod 5,]
R3442 T3954 T3950 conj ],]
R3443 T3955 T3954 punct ",",]
R3444 T3956 T3958 nmod [,]
R3445 T3957 T3958 nummod 32,]
R3446 T3958 T3954 conj ],]
R3447 T3959 T3958 punct ",",]
R3448 T3960 T3958 conj [,]
R3449 T3961 T3962 nummod 36,]
R3450 T3962 T3958 conj ],]
R3451 T3963 T3962 punct ",",]
R3452 T3964 T3962 conj [,]
R3453 T3965 T3966 nummod 37,]
R3454 T3966 T3962 conj ],]
R3455 T3967 T3922 punct .,produce
R3456 T3968 T3970 aux To,examine
R3457 T3969 T3970 advmod further,examine
R3458 T3970 T3983 advcl examine,stimulated
R3459 T3971 T3972 det this,relationship
R3460 T3972 T3970 dobj relationship,examine
R3461 T3973 T3983 punct ",",stimulated
R3462 T3974 T3983 nsubjpass PBMCs,stimulated
R3463 T3975 T3974 prep from,PBMCs
R3464 T3976 T3977 compound CF,patients
R3465 T3977 T3975 pobj patients,from
R3466 T3978 T3977 cc and,patients
R3467 T3979 T3981 amod healthy,controls
R3468 T3980 T3981 compound adult,controls
R3469 T3981 T3977 conj controls,patients
R3470 T3982 T3983 auxpass were,stimulated
R3471 T3983 T3983 ROOT stimulated,stimulated
R3472 T3984 T3983 prep with,stimulated
R3473 T3985 T3984 pobj PAO1,with
R3474 T3986 T3985 punct ",",PAO1
R3475 T3987 T3985 conj LPS+ATP,PAO1
R3476 T3988 T3987 punct ",",LPS+ATP
R3477 T3989 T3987 cc and,LPS+ATP
R3478 T3990 T3991 compound LPS+P,oly
R3479 T3991 T3987 conj oly,LPS+ATP
R3480 T3992 T3995 punct (,dT
R3481 T3993 T3995 nmod dA,dT
R3482 T3994 T3995 punct :,dT
R3483 T3995 T3991 appos dT,oly
R3484 T3996 T3995 punct ),dT
R3485 T3997 T3983 punct ",",stimulated
R3486 T3998 T3999 aux to,activate
R3487 T3999 T3983 advcl activate,stimulated
R3488 T4000 T4001 det the,NLRC4
R3489 T4001 T3999 dobj NLRC4,activate
R3490 T4002 T4001 punct ",",NLRC4
R3491 T4003 T4001 conj NLRP3,NLRC4
R3492 T4004 T4003 punct ",",NLRP3
R3493 T4005 T4003 cc and,NLRP3
R3494 T4006 T4003 conj AIM2,NLRP3
R3495 T4007 T4001 appos inflammasomes,NLRC4
R3496 T4008 T4007 punct ",",inflammasomes
R3497 T4009 T4007 advmod respectively,inflammasomes
R3498 T4010 T3983 punct .,stimulated
R3499 T4011 T4021 prep By,produce
R3500 T4012 T4013 nummod 24,hours
R3501 T4013 T4011 pobj hours,By
R3502 T4014 T4013 prep of,hours
R3503 T4015 T4014 pobj stimulation,of
R3504 T4016 T4021 punct ",",produce
R3505 T4017 T4018 compound CF,PBMCs
R3506 T4018 T4021 nsubj PBMCs,produce
R3507 T4019 T4021 aux did,produce
R3508 T4020 T4021 neg not,produce
R3509 T4021 T4021 ROOT produce,produce
R3510 T4022 T4023 amod increased,amounts
R3511 T4023 T4021 dobj amounts,produce
R3512 T4024 T4023 prep of,amounts
R3513 T4025 T4024 pobj IL-1β,of
R3514 T4026 T4023 punct (,amounts
R3515 T4027 T4023 appos Fig.,amounts
R3516 T4028 T4027 nummod 5a,Fig.
R3517 T4029 T4027 punct ),Fig.
R3518 T4030 T4027 cc or,Fig.
R3519 T4031 T4027 conj IL-8,Fig.
R3520 T4032 T4033 punct (,Fig.
R3521 T4033 T4031 appos Fig.,IL-8
R3522 T4034 T4033 nummod 5b,Fig.
R3523 T4035 T4031 punct ),IL-8
R3524 T4036 T4037 advmod when,compared
R3525 T4037 T4021 advcl compared,produce
R3526 T4038 T4037 prep to,compared
R3527 T4039 T4040 amod healthy,controls
R3528 T4040 T4038 pobj controls,to
R3529 T4041 T4021 punct .,produce
R3530 T4042 T4046 advmod However,notice
R3531 T4043 T4046 punct ",",notice
R3532 T4044 T4046 nsubj we,notice
R3533 T4045 T4046 aux did,notice
R3534 T4046 T4046 ROOT notice,notice
R3535 T4047 T4049 det a,decrease
R3536 T4048 T4049 amod transient,decrease
R3537 T4049 T4046 dobj decrease,notice
R3538 T4050 T4051 punct (,P
R3539 T4051 T4049 appos P,decrease
R3540 T4052 T4051 nummod <,P
R3541 T4053 T4051 nummod 0.001,P
R3542 T4054 T4051 punct ),P
R3543 T4055 T4049 prep in,decrease
R3544 T4056 T4057 det the,amount
R3545 T4057 T4055 pobj amount,in
R3546 T4058 T4057 prep of,amount
R3547 T4059 T4074 dobj IL-1β,shown
R3548 T4060 T4059 acl produced,IL-1β
R3549 T4061 T4060 agent by,produced
R3550 T4062 T4063 compound CF,cells
R3551 T4063 T4061 pobj cells,by
R3552 T4064 T4060 prep in,produced
R3553 T4065 T4064 pobj response,in
R3554 T4066 T4065 prep to,response
R3555 T4067 T4066 pobj LPS+ATP,to
R3556 T4068 T4065 prep at,response
R3557 T4069 T4070 nummod 6,hours
R3558 T4070 T4068 pobj hours,at
R3559 T4071 T4074 punct (,shown
R3560 T4072 T4074 nsubj data,shown
R3561 T4073 T4074 neg not,shown
R3562 T4074 T4049 relcl shown,decrease
R3563 T4075 T4049 punct ),decrease
R3564 T4076 T4046 punct .,notice
R3565 T4077 T4098 nsubj Stimulation,produced
R3566 T4078 T4077 prep of,Stimulation
R3567 T4079 T4078 pobj PBMCs,of
R3568 T4080 T4079 prep with,PBMCs
R3569 T4081 T4082 compound P.,aeruginosa
R3570 T4082 T4080 pobj aeruginosa,with
R3571 T4083 T4084 nsubj that,lacks
R3572 T4084 T4082 relcl lacks,aeruginosa
R3573 T4085 T4084 dobj exsA,lacks
R3574 T4086 T4087 punct (,PAO1ΔexsA
R3575 T4087 T4085 appos PAO1ΔexsA,exsA
R3576 T4088 T4077 punct ),Stimulation
R3577 T4089 T4077 punct ",",Stimulation
R3578 T4090 T4092 det a,regulator
R3579 T4091 T4092 amod key,regulator
R3580 T4092 T4077 appos regulator,Stimulation
R3581 T4093 T4092 prep of,regulator
R3582 T4094 T4096 compound type,secretion
R3583 T4095 T4096 compound III,secretion
R3584 T4096 T4093 pobj secretion,of
R3585 T4097 T4098 punct ",",produced
R3586 T4098 T4098 ROOT produced,produced
R3587 T4099 T4101 amod three-fold,IL-1β
R3588 T4100 T4101 advmod less,IL-1β
R3589 T4101 T4102 amod IL-1β,compared
R3590 T4102 T4098 prep compared,produced
R3591 T4103 T4102 prep to,compared
R3592 T4104 T4107 det the,strain
R3593 T4105 T4107 amod parental,strain
R3594 T4106 T4107 compound PAO1,strain
R3595 T4107 T4103 pobj strain,to
R3596 T4108 T4107 prep by,strain
R3597 T4109 T4110 nummod 24,hours
R3598 T4110 T4108 pobj hours,by
R3599 T4111 T4110 punct (,hours
R3600 T4112 T4110 appos Fig.,hours
R3601 T4113 T4112 nummod 5a,Fig.
R3602 T4114 T4110 punct ),hours
R3603 T4115 T4098 punct .,produced
R3604 T4116 T4117 amod Inflammasome,stimulation
R3605 T4117 T4122 nsubj stimulation,result
R3606 T4118 T4117 prep without,stimulation
R3607 T4119 T4118 pcomp priming,without
R3608 T4120 T4122 aux did,result
R3609 T4121 T4122 neg not,result
R3610 T4122 T4122 ROOT result,result
R3611 T4123 T4122 prep in,result
R3612 T4124 T4126 det any,production
R3613 T4125 T4126 amod IL-1β,production
R3614 T4126 T4123 pobj production,in
R3615 T4127 T4126 prep in,production
R3616 T4128 T4129 det either,CF
R3617 T4129 T4127 pobj CF,in
R3618 T4130 T4129 cc or,CF
R3619 T4131 T4132 compound control,PBMCs
R3620 T4132 T4129 conj PBMCs,CF
R3621 T4133 T4122 punct .,result
R3622 T4134 T4141 advcl Contrary,indicate
R3623 T4135 T4134 prep to,Contrary
R3624 T4136 T4137 poss our,hypothesis
R3625 T4137 T4135 pobj hypothesis,to
R3626 T4138 T4141 punct ",",indicate
R3627 T4139 T4140 det these,results
R3628 T4140 T4141 nsubj results,indicate
R3629 T4141 T4141 ROOT indicate,indicate
R3630 T4142 T4149 mark that,display
R3631 T4143 T4149 nsubj PBMCs,display
R3632 T4144 T4143 prep from,PBMCs
R3633 T4145 T4146 compound CF,patients
R3634 T4146 T4144 pobj patients,from
R3635 T4147 T4149 aux do,display
R3636 T4148 T4149 neg not,display
R3637 T4149 T4141 ccomp display,indicate
R3638 T4150 T4151 amod increased,production
R3639 T4151 T4149 dobj production,display
R3640 T4152 T4151 prep of,production
R3641 T4153 T4152 pobj IL-1β,of
R3642 T4154 T4153 cc or,IL-1β
R3643 T4155 T4153 conj IL-8,IL-1β
R3644 T4156 T4149 prep with,display
R3645 T4157 T4158 amod inflammasome,activation
R3646 T4158 T4156 pobj activation,with
R3647 T4159 T4149 cc nor,display
R3648 T4160 T4162 aux do,suggest
R3649 T4161 T4162 nsubj they,suggest
R3650 T4162 T4149 conj suggest,display
R3651 T4163 T4165 det any,basal
R3652 T4164 T4165 amod increased,basal
R3653 T4165 T4162 dobj basal,suggest
R3654 T4166 T4165 cc or,basal
R3655 T4167 T4169 amod induced,activity
R3656 T4168 T4169 compound NF-κB,activity
R3657 T4169 T4165 conj activity,basal
R3658 T4170 T4141 punct .,indicate
R3659 T4171 T4172 det These,results
R3660 T4172 T4173 nsubj results,are
R3661 T4173 T4173 ROOT are,are
R3662 T4174 T4173 acomp consistent,are
R3663 T4175 T4174 prep with,consistent
R3664 T4176 T4177 poss our,observation
R3665 T4177 T4175 pobj observation,with
R3666 T4178 T4181 mark that,is
R3667 T4179 T4180 amod caspase-1,activity
R3668 T4180 T4181 nsubj activity,is
R3669 T4181 T4173 advcl is,are
R3670 T4182 T4181 neg not,is
R3671 T4183 T4181 acomp different,is
R3672 T4184 T4183 prep between,different
R3673 T4185 T4184 pobj CF,between
R3674 T4186 T4185 cc and,CF
R3675 T4187 T4188 compound control,PBMCs
R3676 T4188 T4185 conj PBMCs,CF
R3677 T4189 T4190 punct (,Fig.
R3678 T4190 T4188 appos Fig.,PBMCs
R3679 T4191 T4190 nummod 4,Fig.
R3680 T4192 T4188 punct ),PBMCs
R3681 T4193 T4173 punct .,are
R12214 T13759 T13759 ROOT produce,produce
R12208 T13753 T13759 nsubj PBMCs,produce
R12209 T13754 T13753 prep from,PBMCs
R12210 T13755 T13756 compound CF,patients
R12211 T13756 T13754 pobj patients,from
R12212 T13757 T13759 aux do,produce
R12213 T13758 T13759 neg not,produce
R12215 T13760 T13761 amod increased,amounts
R12216 T13761 T13759 dobj amounts,produce
R12217 T13762 T13761 prep of,amounts
R12218 T13763 T13762 pobj IL-1β,of
R12219 T13764 T13759 punct .,produce
R12220 T13765 T13770 nsubj PBMCs,n
R12221 T13766 T13765 prep from,PBMCs
R12222 T13767 T13768 compound CF,patients
R12223 T13768 T13766 pobj patients,from
R12224 T13769 T13768 punct (,patients
R12225 T13770 T13770 ROOT n,n
R12226 T13771 T13772 punct =,17
R12227 T13772 T13770 nummod 17,n
R12228 T13773 T13772 appos 20,17
R12229 T13774 T13772 punct ),17
R12230 T13775 T13770 cc and,n
R12231 T13776 T13777 amod healthy,controls
R12232 T13777 T13770 conj controls,n
R12233 T13778 T13777 punct (,controls
R12234 T13779 T13785 nsubjpass n,primed
R12235 T13780 T13781 punct =,15
R12236 T13781 T13779 prep 15,n
R12237 T13782 T13781 appos 19,15
R12238 T13783 T13781 punct ),15
R12239 T13784 T13785 auxpass were,primed
R12240 T13785 T13785 ROOT primed,primed
R12241 T13786 T13785 prep with,primed
R12242 T13787 T13786 pobj LPS,with
R12243 T13788 T13787 punct (,LPS
R12244 T13789 T13790 nummod 10,ng/ml
R12245 T13790 T13787 appos ng/ml,LPS
R12246 T13791 T13790 punct ),ng/ml
R12247 T13792 T13787 conj overnight,LPS
R12248 T13793 T13792 cc and,overnight
R12249 T13794 T13792 conj stimulated,overnight
R12250 T13795 T13794 prep with,stimulated
R12251 T13796 T13798 compound P.,PAO1
R12252 T13797 T13798 compound aeruginosa,PAO1
R12253 T13798 T13795 pobj PAO1,with
R12254 T13799 T13808 punct (,lacking
R12255 T13800 T13808 nsubj MOI,lacking
R12256 T13801 T13802 punct =,1
R12257 T13802 T13800 nummod 1,MOI
R12258 T13803 T13802 punct ),1
R12259 T13804 T13800 punct ",",MOI
R12260 T13805 T13807 compound P.,PAO1
R12261 T13806 T13807 compound aeruginosa,PAO1
R12262 T13807 T13808 nsubj PAO1,lacking
R12263 T13808 T13808 ROOT lacking,lacking
R12264 T13809 T13808 dobj exsA,lacking
R12265 T13810 T13819 punct (,mM
R12266 T13811 T13819 nmod MOI,mM
R12267 T13812 T13813 punct =,1
R12268 T13813 T13811 nummod 1,MOI
R12269 T13814 T13813 punct ),1
R12270 T13815 T13811 punct ",",MOI
R12271 T13816 T13811 conj ATP,MOI
R12272 T13817 T13818 punct (,5
R12273 T13818 T13819 nummod 5,mM
R12274 T13819 T13809 appos mM,exsA
R12275 T13820 T13819 punct ),mM
R12276 T13821 T13809 punct ",",exsA
R12277 T13822 T13809 cc or,exsA
R12278 T13823 T13809 conj Poly,exsA
R12279 T13824 T13823 punct (,Poly
R12280 T13825 T13833 nmod dA,ml
R12281 T13826 T13825 punct :,dA
R12282 T13827 T13825 appos dT,dA
R12283 T13828 T13825 punct ),dA
R12284 T13829 T13833 punct (,ml
R12285 T13830 T13831 nummod 1,µg
R12286 T13831 T13833 nmod µg,ml
R12287 T13832 T13833 compound /,ml
R12288 T13833 T13823 appos ml,Poly
R12289 T13834 T13823 punct ),Poly
R12290 T13835 T13808 prep for,lacking
R12291 T13836 T13837 nummod 24,hours
R12292 T13837 T13835 pobj hours,for
R12293 T13838 T13808 punct .,lacking
R12294 T13839 T13840 compound P.,aeruginosa
R12295 T13840 T13844 nsubjpass aeruginosa,used
R12296 T13841 T13840 acl lacking,aeruginosa
R12297 T13842 T13841 dobj exsA,lacking
R12298 T13843 T13844 auxpass was,used
R12299 T13844 T13844 ROOT used,used
R12300 T13845 T13844 prep as,used
R12301 T13846 T13850 det a,control
R12302 T13847 T13850 compound type,control
R12303 T13848 T13850 compound III,control
R12304 T13849 T13850 compound secretion,control
R12305 T13850 T13845 pobj control,as
R12306 T13851 T13850 prep in,control
R12307 T13852 T13851 pobj comparison,in
R12308 T13853 T13852 prep with,comparison
R12309 T13854 T13856 amod wild-type,aeruginosa
R12310 T13855 T13856 compound P.,aeruginosa
R12311 T13856 T13853 pobj aeruginosa,with
R12312 T13857 T13844 punct .,used
R12313 T13858 T13860 nsubjpass Supernatants,assayed
R12314 T13859 T13860 auxpass were,assayed
R12315 T13860 T13860 ROOT assayed,assayed
R12316 T13861 T13860 prep for,assayed
R12317 T13862 T13863 punct (,A
R12318 T13863 T13861 pobj A,for
R12319 T13864 T13863 punct ),A
R12320 T13865 T13860 advcl IL-1β,assayed
R12321 T13866 T13865 cc and,IL-1β
R12322 T13867 T13868 punct (,B
R12323 T13868 T13865 conj B,IL-1β
R12324 T13869 T13868 punct ),B
R12325 T13870 T13865 conj IL-8,IL-1β
R12326 T13871 T13860 punct .,assayed

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T3638 0-5 NN denotes PBMCs
T3639 6-10 IN denotes from
T3640 11-13 NN denotes CF
T3641 14-22 NN denotes patients
T3642 23-25 VB denotes do
T3643 26-29 RB denotes not
T3644 30-37 VB denotes produce
T3645 38-47 VB denotes increased
T3646 48-55 NN denotes amounts
T3647 56-58 IN denotes of
T3648 59-64 NN denotes IL-1β
T3649 65-69 IN denotes upon
T3650 70-82 JJ denotes inflammasome
T3651 83-94 NN denotes stimulation
T3652 95-103 JJ denotes Previous
T3653 104-111 NN denotes studies
T3654 112-116 VB denotes have
T3655 117-122 VB denotes shown
T3656 123-127 IN denotes that
T3657 128-131 DT denotes the
T3658 132-136 NN denotes loss
T3659 137-139 IN denotes of
T3660 140-144 NN denotes CFTR
T3661 145-152 VB denotes results
T3662 153-155 IN denotes in
T3663 156-165 VB denotes increased
T3664 166-171 NN denotes NF-κB
T3665 172-180 NN denotes activity
T3666 181-184 CC denotes and
T3667 185-201 JJ denotes pro-inflammatory
T3668 202-210 NN denotes cytokine
T3669 211-220 NN denotes secretion
T3670 221-222 -LRB- denotes [
T3671 222-223 CD denotes 4
T3672 223-224 -RRB- denotes ]
T3673 224-225 -COMMA- denotes ,
T3674 226-227 -LRB- denotes [
T3675 227-228 CD denotes 5
T3676 228-229 -RRB- denotes ]
T3677 229-230 -COMMA- denotes ,
T3678 231-232 -LRB- denotes [
T3679 232-234 CD denotes 32
T3680 234-235 -RRB- denotes ]
T3681 235-236 -COMMA- denotes ,
T3682 237-238 -LRB- denotes [
T3683 238-240 CD denotes 36
T3684 240-241 -RRB- denotes ]
T3685 241-242 -COMMA- denotes ,
T3686 243-244 -LRB- denotes [
T3687 244-246 CD denotes 37
T3688 246-247 -RRB- denotes ]
T3689 249-251 TO denotes To
T3690 252-259 RB denotes further
T3691 260-267 VB denotes examine
T3692 268-272 DT denotes this
T3693 273-285 NN denotes relationship
T3694 285-286 -COMMA- denotes ,
T3695 287-292 NN denotes PBMCs
T3696 293-297 IN denotes from
T3697 298-300 NN denotes CF
T3698 301-309 NN denotes patients
T3699 310-313 CC denotes and
T3700 314-321 JJ denotes healthy
T3701 322-327 JJ denotes adult
T3702 328-336 NN denotes controls
T3703 337-341 VB denotes were
T3704 342-352 VB denotes stimulated
T3705 353-357 IN denotes with
T3706 358-362 NN denotes PAO1
T3707 362-363 -COMMA- denotes ,
T3708 364-371 NN denotes LPS+ATP
T3709 371-372 -COMMA- denotes ,
T3710 373-376 CC denotes and
T3711 377-385 NN denotes LPS+Poly
T3712 385-386 -LRB- denotes (
T3713 386-388 NN denotes dA
T3714 388-389 -COLON- denotes :
T3715 389-391 NN denotes dT
T3716 391-392 -RRB- denotes )
T3717 392-393 -COMMA- denotes ,
T3718 394-396 TO denotes to
T3719 397-405 VB denotes activate
T3720 406-409 DT denotes the
T3721 410-415 NN denotes NLRC4
T3722 415-416 -COMMA- denotes ,
T3723 417-422 NN denotes NLRP3
T3724 422-423 -COMMA- denotes ,
T3725 424-427 CC denotes and
T3726 428-432 NN denotes AIM2
T3727 433-446 NN denotes inflammasomes
T3728 446-447 -COMMA- denotes ,
T3729 448-460 RB denotes respectively
T3730 462-464 IN denotes By
T3731 465-467 CD denotes 24
T3732 468-473 NN denotes hours
T3733 474-476 IN denotes of
T3734 477-488 NN denotes stimulation
T3735 488-489 -COMMA- denotes ,
T3736 490-492 NN denotes CF
T3737 493-498 NN denotes PBMCs
T3738 499-502 VB denotes did
T3739 503-506 RB denotes not
T3740 507-514 VB denotes produce
T3741 515-524 VB denotes increased
T3742 525-532 NN denotes amounts
T3743 533-535 IN denotes of
T3744 536-541 NN denotes IL-1β
T3745 542-543 -LRB- denotes (
T3746 543-547 NN denotes Fig.
T3747 548-550 NN denotes 5a
T3748 550-551 -RRB- denotes )
T3749 552-554 CC denotes or
T3750 555-559 NN denotes IL-8
T3751 560-561 -LRB- denotes (
T3752 561-565 NN denotes Fig.
T3753 566-568 NN denotes 5b
T3754 568-569 -RRB- denotes )
T3755 570-574 WRB denotes when
T3756 575-583 VB denotes compared
T3757 584-586 TO denotes to
T3758 587-594 JJ denotes healthy
T3759 595-603 NN denotes controls
T3760 605-612 RB denotes However
T3761 612-613 -COMMA- denotes ,
T3762 614-616 PRP denotes we
T3763 617-620 VB denotes did
T3764 621-627 VB denotes notice
T3765 628-629 DT denotes a
T3766 630-639 JJ denotes transient
T3767 640-648 NN denotes decrease
T3768 649-650 -LRB- denotes (
T3769 650-651 NN denotes P
T3770 651-652 SYM denotes <
T3771 652-657 CD denotes 0.001
T3772 657-658 -RRB- denotes )
T3773 659-661 IN denotes in
T3774 662-665 DT denotes the
T3775 666-672 NN denotes amount
T3776 673-675 IN denotes of
T3777 676-681 NN denotes IL-1β
T3778 682-690 VB denotes produced
T3779 691-693 IN denotes by
T3780 694-696 NN denotes CF
T3781 697-702 NN denotes cells
T3782 703-705 IN denotes in
T3783 706-714 NN denotes response
T3784 715-717 TO denotes to
T3785 718-725 NN denotes LPS+ATP
T3786 726-728 IN denotes at
T3787 729-730 CD denotes 6
T3788 731-736 NN denotes hours
T3789 737-738 -LRB- denotes (
T3790 738-742 NN denotes data
T3791 743-746 RB denotes not
T3792 747-752 VB denotes shown
T3793 752-753 -RRB- denotes )
T3794 755-766 NN denotes Stimulation
T3795 767-769 IN denotes of
T3796 770-775 NN denotes PBMCs
T3797 776-780 IN denotes with
T3798 781-783 NNP denotes P.
T3799 784-794 NN denotes aeruginosa
T3800 795-799 WDT denotes that
T3801 800-805 VB denotes lacks
T3802 806-810 NN denotes exsA
T3803 811-812 -LRB- denotes (
T3804 812-821 NN denotes PAO1ΔexsA
T3805 821-822 -RRB- denotes )
T3806 822-823 -COMMA- denotes ,
T3807 824-825 DT denotes a
T3808 826-829 JJ denotes key
T3809 830-839 NN denotes regulator
T3810 840-842 IN denotes of
T3811 843-847 NN denotes type
T3812 848-851 CD denotes III
T3813 852-861 NN denotes secretion
T3814 861-862 -COMMA- denotes ,
T3815 863-871 VB denotes produced
T3816 872-882 RB denotes three-fold
T3817 883-887 JJ denotes less
T3818 888-893 NN denotes IL-1β
T3819 894-902 VB denotes compared
T3820 903-905 TO denotes to
T3821 906-909 DT denotes the
T3822 910-918 JJ denotes parental
T3823 919-923 NN denotes PAO1
T3824 924-930 NN denotes strain
T3825 931-933 IN denotes by
T3826 934-936 CD denotes 24
T3827 937-942 NN denotes hours
T3828 943-944 -LRB- denotes (
T3829 944-948 NNP denotes Fig.
T3830 949-951 NN denotes 5a
T3831 951-952 -RRB- denotes )
T3832 954-966 JJ denotes Inflammasome
T3833 967-978 NN denotes stimulation
T3834 979-986 IN denotes without
T3835 987-994 NN denotes priming
T3836 995-998 VB denotes did
T3837 999-1002 RB denotes not
T3838 1003-1009 VB denotes result
T3839 1010-1012 IN denotes in
T3840 1013-1016 DT denotes any
T3841 1017-1022 NN denotes IL-1β
T3842 1023-1033 NN denotes production
T3843 1034-1036 IN denotes in
T3844 1037-1043 CC denotes either
T3845 1044-1046 NN denotes CF
T3846 1047-1049 CC denotes or
T3847 1050-1057 NN denotes control
T3848 1058-1063 NN denotes PBMCs
T3849 1065-1073 JJ denotes Contrary
T3850 1074-1076 TO denotes to
T3851 1077-1080 PRP-DOLLAR- denotes our
T3852 1081-1091 NN denotes hypothesis
T3853 1091-1092 -COMMA- denotes ,
T3854 1093-1098 DT denotes these
T3855 1099-1106 NN denotes results
T3856 1107-1115 VB denotes indicate
T3857 1116-1120 IN denotes that
T3858 1121-1126 NN denotes PBMCs
T3859 1127-1131 IN denotes from
T3860 1132-1134 NN denotes CF
T3861 1135-1143 NN denotes patients
T3862 1144-1146 VB denotes do
T3863 1147-1150 RB denotes not
T3864 1151-1158 VB denotes display
T3865 1159-1168 VB denotes increased
T3866 1169-1179 NN denotes production
T3867 1180-1182 IN denotes of
T3868 1183-1188 NN denotes IL-1β
T3869 1189-1191 CC denotes or
T3870 1192-1196 NN denotes IL-8
T3871 1197-1201 IN denotes with
T3872 1202-1214 JJ denotes inflammasome
T3873 1215-1225 NN denotes activation
T3874 1226-1229 CC denotes nor
T3875 1230-1232 VB denotes do
T3876 1233-1237 PRP denotes they
T3877 1238-1245 VB denotes suggest
T3878 1246-1249 DT denotes any
T3879 1250-1259 VB denotes increased
T3880 1260-1265 JJ denotes basal
T3881 1266-1268 CC denotes or
T3882 1269-1276 VB denotes induced
T3883 1277-1282 NN denotes NF-κB
T3884 1283-1291 NN denotes activity
T3885 1293-1298 DT denotes These
T3886 1299-1306 NN denotes results
T3887 1307-1310 VB denotes are
T3888 1311-1321 JJ denotes consistent
T3889 1322-1326 IN denotes with
T3890 1327-1330 PRP-DOLLAR- denotes our
T3891 1331-1342 NN denotes observation
T3892 1343-1347 IN denotes that
T3893 1348-1357 NN denotes caspase-1
T3894 1358-1366 NN denotes activity
T3895 1367-1369 VB denotes is
T3896 1370-1373 RB denotes not
T3897 1374-1383 JJ denotes different
T3898 1384-1391 IN denotes between
T3899 1392-1394 NN denotes CF
T3900 1395-1398 CC denotes and
T3901 1399-1406 NN denotes control
T3902 1407-1412 NN denotes PBMCs
T3903 1413-1414 -LRB- denotes (
T3904 1414-1418 NN denotes Fig.
T3905 1419-1420 CD denotes 4
T3906 1420-1421 -RRB- denotes )
T13645 1467-1472 NN denotes PBMCs
T13646 1473-1477 IN denotes from
T13647 1478-1480 NN denotes CF
T13648 1481-1489 NN denotes patients
T13649 1490-1492 VB denotes do
T13650 1493-1496 RB denotes not
T13651 1497-1504 VB denotes produce
T13652 1505-1514 VB denotes increased
T13653 1515-1522 NN denotes amounts
T13654 1523-1525 IN denotes of
T13655 1526-1531 NN denotes IL-1β
T13656 1533-1538 NN denotes PBMCs
T13657 1539-1543 IN denotes from
T13658 1544-1546 NN denotes CF
T13659 1547-1555 NN denotes patients
T13660 1556-1557 -LRB- denotes (
T13661 1557-1566 NN denotes n = 17–20
T13662 1566-1567 -RRB- denotes )
T13663 1568-1571 CC denotes and
T13664 1572-1579 JJ denotes healthy
T13665 1580-1588 NN denotes controls
T13666 1589-1590 -LRB- denotes (
T13667 1590-1599 NN denotes n = 15–19
T13668 1599-1600 -RRB- denotes )
T13669 1601-1605 VB denotes were
T13670 1606-1612 VB denotes primed
T13671 1613-1617 IN denotes with
T13672 1618-1621 NN denotes LPS
T13673 1622-1623 -LRB- denotes (
T13674 1623-1625 CD denotes 10
T13675 1626-1631 NN denotes ng/ml
T13676 1631-1632 -RRB- denotes )
T13677 1633-1642 JJ denotes overnight
T13678 1643-1646 CC denotes and
T13679 1647-1657 VB denotes stimulated
T13680 1658-1662 IN denotes with
T13681 1663-1665 NNP denotes P.
T13682 1666-1676 NN denotes aeruginosa
T13683 1677-1681 NN denotes PAO1
T13684 1682-1683 -LRB- denotes (
T13685 1683-1690 NN denotes MOI = 1
T13686 1690-1691 -RRB- denotes )
T13687 1691-1692 -COMMA- denotes ,
T13688 1693-1695 NNP denotes P.
T13689 1696-1706 NN denotes aeruginosa
T13690 1707-1711 NN denotes PAO1
T13691 1712-1719 VB denotes lacking
T13692 1720-1724 NN denotes exsA
T13693 1725-1726 -LRB- denotes (
T13694 1726-1733 NN denotes MOI = 1
T13695 1733-1734 -RRB- denotes )
T13696 1734-1735 -COMMA- denotes ,
T13697 1736-1739 NN denotes ATP
T13698 1740-1741 -LRB- denotes (
T13699 1741-1742 CD denotes 5
T13700 1743-1745 NN denotes mM
T13701 1745-1746 -RRB- denotes )
T13702 1746-1747 -COMMA- denotes ,
T13703 1748-1750 CC denotes or
T13704 1751-1755 NNP denotes Poly
T13705 1755-1756 -LRB- denotes (
T13706 1756-1758 NN denotes dA
T13707 1758-1759 -COLON- denotes :
T13708 1759-1761 NN denotes dT
T13709 1761-1762 -RRB- denotes )
T13710 1763-1764 -LRB- denotes (
T13711 1764-1765 CD denotes 1
T13712 1766-1771 NN denotes µg/ml
T13713 1771-1772 -RRB- denotes )
T13714 1773-1776 IN denotes for
T13715 1777-1779 CD denotes 24
T13716 1780-1785 NN denotes hours
T13717 1787-1789 NN denotes P.
T13718 1790-1800 NN denotes aeruginosa
T13719 1801-1808 VB denotes lacking
T13720 1809-1813 NN denotes exsA
T13721 1814-1817 VB denotes was
T13722 1818-1822 VB denotes used
T13723 1823-1825 IN denotes as
T13724 1826-1827 DT denotes a
T13725 1828-1832 NN denotes type
T13726 1833-1836 CD denotes III
T13727 1837-1846 NN denotes secretion
T13728 1847-1854 NN denotes control
T13729 1855-1857 IN denotes in
T13730 1858-1868 NN denotes comparison
T13731 1869-1873 IN denotes with
T13732 1874-1883 JJ denotes wild-type
T13733 1884-1886 NNP denotes P.
T13734 1887-1897 NN denotes aeruginosa
T13735 1899-1911 NN denotes Supernatants
T13736 1912-1916 VB denotes were
T13737 1917-1924 VB denotes assayed
T13738 1925-1928 IN denotes for
T13739 1929-1930 -LRB- denotes (
T13740 1930-1931 NN denotes A
T13741 1931-1932 -RRB- denotes )
T13742 1933-1938 NN denotes IL-1β
T13743 1939-1942 CC denotes and
T13744 1943-1944 -LRB- denotes (
T13745 1944-1945 NN denotes B
T13746 1945-1946 -RRB- denotes )
T13747 1947-1951 NN denotes IL-8
R3130 T3638 T3639 arg1Of PBMCs,from
R3131 T3638 T3642 arg1Of PBMCs,do
R3132 T3638 T3644 arg1Of PBMCs,produce
R3133 T3641 T3639 arg2Of patients,from
R3134 T3641 T3640 arg1Of patients,CF
R3135 T3644 T3642 arg2Of produce,do
R3136 T3644 T3643 arg1Of produce,not
R3137 T3644 T3649 arg1Of produce,upon
R3138 T3646 T3644 arg2Of amounts,produce
R3139 T3646 T3645 arg2Of amounts,increased
R3140 T3646 T3647 arg1Of amounts,of
R3141 T3648 T3647 arg2Of IL-1β,of
R3142 T3651 T3649 arg2Of stimulation,upon
R3143 T3651 T3650 arg1Of stimulation,inflammasome
R3144 T3653 T3652 arg1Of studies,Previous
R3145 T3653 T3654 arg1Of studies,have
R3146 T3653 T3655 arg1Of studies,shown
R3147 T3655 T3654 arg2Of shown,have
R3148 T3655 T3681 arg1Of shown,","
R3149 T3655 T3682 arg1Of shown,[
R3150 T3655 T3685 arg1Of shown,","
R3151 T3655 T3686 arg1Of shown,[
R3152 T3658 T3657 arg1Of loss,the
R3153 T3658 T3659 arg1Of loss,of
R3154 T3658 T3661 arg1Of loss,results
R3155 T3660 T3659 arg2Of CFTR,of
R3156 T3661 T3655 arg2Of results,shown
R3157 T3661 T3656 arg1Of results,that
R3158 T3661 T3662 arg1Of results,in
R3159 T3661 T3673 arg1Of results,","
R3160 T3661 T3674 arg1Of results,[
R3161 T3661 T3677 arg1Of results,","
R3162 T3661 T3678 arg1Of results,[
R3163 T3665 T3663 arg2Of activity,increased
R3164 T3665 T3664 arg1Of activity,NF-κB
R3165 T3665 T3666 arg1Of activity,and
R3166 T3666 T3662 arg2Of and,in
R3167 T3669 T3666 arg2Of secretion,and
R3168 T3669 T3667 arg1Of secretion,pro-inflammatory
R3169 T3669 T3668 arg1Of secretion,cytokine
R3170 T3669 T3670 arg1Of secretion,[
R3171 T3671 T3670 arg2Of 4,[
R3172 T3672 T3670 arg3Of ],[
R3173 T3675 T3674 arg2Of 5,[
R3174 T3676 T3674 arg3Of ],[
R3175 T3679 T3678 arg2Of 32,[
R3176 T3680 T3678 arg3Of ],[
R3177 T3683 T3682 arg2Of 36,[
R3178 T3684 T3682 arg3Of ],[
R3179 T3687 T3686 arg2Of 37,[
R3180 T3688 T3686 arg3Of ],[
R3181 T3691 T3689 arg1Of examine,To
R3182 T3691 T3690 arg1Of examine,further
R3183 T3693 T3691 arg2Of relationship,examine
R3184 T3693 T3692 arg1Of relationship,this
R3185 T3695 T3691 arg1Of PBMCs,examine
R3186 T3695 T3696 arg1Of PBMCs,from
R3187 T3695 T3703 arg1Of PBMCs,were
R3188 T3695 T3704 arg2Of PBMCs,stimulated
R3189 T3698 T3697 arg1Of patients,CF
R3190 T3698 T3699 arg1Of patients,and
R3191 T3699 T3696 arg2Of and,from
R3192 T3701 T3700 arg1Of adult,healthy
R3193 T3702 T3699 arg2Of controls,and
R3194 T3702 T3701 arg1Of controls,adult
R3195 T3704 T3689 modOf stimulated,To
R3196 T3704 T3694 arg1Of stimulated,","
R3197 T3704 T3703 arg2Of stimulated,were
R3198 T3704 T3705 arg1Of stimulated,with
R3199 T3706 T3707 arg1Of PAO1,","
R3200 T3707 T3710 arg1Of ",",and
R3201 T3708 T3707 arg2Of LPS+ATP,","
R3202 T3710 T3705 arg2Of and,with
R3203 T3710 T3709 arg1Of and,","
R3204 T3710 T3717 arg1Of and,","
R3205 T3711 T3710 arg2Of LPS+Poly,and
R3206 T3711 T3712 arg1Of LPS+Poly,(
R3207 T3713 T3712 arg2Of dA,(
R3208 T3713 T3714 arg1Of dA,:
R3209 T3713 T3715 arg1Of dA,dT
R3210 T3716 T3712 arg3Of ),(
R3211 T3719 T3717 arg2Of activate,","
R3212 T3719 T3718 arg1Of activate,to
R3213 T3719 T3728 arg1Of activate,","
R3214 T3719 T3729 arg1Of activate,respectively
R3215 T3721 T3722 arg1Of NLRC4,","
R3216 T3722 T3725 arg1Of ",",and
R3217 T3723 T3722 arg2Of NLRP3,","
R3218 T3725 T3724 arg1Of and,","
R3219 T3726 T3725 arg2Of AIM2,and
R3220 T3727 T3719 arg2Of inflammasomes,activate
R3221 T3727 T3720 arg1Of inflammasomes,the
R3222 T3727 T3721 arg1Of inflammasomes,NLRC4
R3223 T3727 T3723 arg1Of inflammasomes,NLRP3
R3224 T3727 T3726 arg1Of inflammasomes,AIM2
R3225 T3732 T3730 arg2Of hours,By
R3226 T3732 T3731 arg1Of hours,24
R3227 T3732 T3733 arg1Of hours,of
R3228 T3734 T3733 arg2Of stimulation,of
R3229 T3737 T3736 arg1Of PBMCs,CF
R3230 T3737 T3738 arg1Of PBMCs,did
R3231 T3737 T3740 arg1Of PBMCs,produce
R3232 T3737 T3756 arg1Of PBMCs,compared
R3233 T3740 T3730 arg1Of produce,By
R3234 T3740 T3735 arg1Of produce,","
R3235 T3740 T3738 arg2Of produce,did
R3236 T3740 T3739 arg1Of produce,not
R3237 T3740 T3755 arg1Of produce,when
R3238 T3742 T3740 arg2Of amounts,produce
R3239 T3742 T3741 arg2Of amounts,increased
R3240 T3742 T3743 arg1Of amounts,of
R3241 T3744 T3745 arg1Of IL-1β,(
R3242 T3744 T3749 arg1Of IL-1β,or
R3243 T3747 T3745 arg2Of 5a,(
R3244 T3747 T3746 arg1Of 5a,Fig.
R3245 T3748 T3745 arg3Of ),(
R3246 T3749 T3743 arg2Of or,of
R3247 T3750 T3749 arg2Of IL-8,or
R3248 T3750 T3751 arg1Of IL-8,(
R3249 T3753 T3751 arg2Of 5b,(
R3250 T3753 T3752 arg1Of 5b,Fig.
R3251 T3754 T3751 arg3Of ),(
R3252 T3756 T3755 arg2Of compared,when
R3253 T3756 T3757 arg1Of compared,to
R3254 T3759 T3757 arg2Of controls,to
R3255 T3759 T3758 arg1Of controls,healthy
R3256 T3762 T3763 arg1Of we,did
R3257 T3762 T3764 arg1Of we,notice
R3258 T3764 T3760 arg1Of notice,However
R3259 T3764 T3761 arg1Of notice,","
R3260 T3764 T3763 arg2Of notice,did
R3261 T3764 T3773 arg1Of notice,in
R3262 T3767 T3764 arg2Of decrease,notice
R3263 T3767 T3765 arg1Of decrease,a
R3264 T3767 T3766 arg1Of decrease,transient
R3265 T3767 T3768 arg1Of decrease,(
R3266 T3769 T3768 arg2Of P,(
R3267 T3769 T3770 arg1Of P,<
R3268 T3769 T3771 arg1Of P,0.001
R3269 T3772 T3768 arg3Of ),(
R3270 T3775 T3773 arg2Of amount,in
R3271 T3775 T3774 arg1Of amount,the
R3272 T3775 T3776 arg1Of amount,of
R3273 T3775 T3778 arg2Of amount,produced
R3274 T3777 T3776 arg2Of IL-1β,of
R3275 T3778 T3782 arg1Of produced,in
R3276 T3778 T3786 arg1Of produced,at
R3277 T3781 T3778 arg1Of cells,produced
R3278 T3781 T3779 arg2Of cells,by
R3279 T3781 T3780 arg1Of cells,CF
R3280 T3782 T3784 arg1Of in,to
R3281 T3783 T3782 arg2Of response,in
R3282 T3785 T3782 arg3Of LPS+ATP,in
R3283 T3788 T3786 arg2Of hours,at
R3284 T3788 T3787 arg1Of hours,6
R3285 T3788 T3789 arg1Of hours,(
R3286 T3790 T3789 arg2Of data,(
R3287 T3790 T3792 arg2Of data,shown
R3288 T3792 T3791 arg1Of shown,not
R3289 T3793 T3789 arg3Of ),(
R3290 T3794 T3795 arg1Of Stimulation,of
R3291 T3794 T3797 arg1Of Stimulation,with
R3292 T3794 T3800 arg1Of Stimulation,that
R3293 T3794 T3801 arg1Of Stimulation,lacks
R3294 T3794 T3815 arg1Of Stimulation,produced
R3295 T3796 T3795 arg2Of PBMCs,of
R3296 T3799 T3797 arg2Of aeruginosa,with
R3297 T3799 T3798 arg1Of aeruginosa,P.
R3298 T3802 T3801 arg2Of exsA,lacks
R3299 T3802 T3803 arg1Of exsA,(
R3300 T3802 T3806 arg1Of exsA,","
R3301 T3804 T3803 arg2Of PAO1ΔexsA,(
R3302 T3805 T3803 arg3Of ),(
R3303 T3809 T3806 arg2Of regulator,","
R3304 T3809 T3807 arg1Of regulator,a
R3305 T3809 T3808 arg1Of regulator,key
R3306 T3809 T3810 arg1Of regulator,of
R3307 T3813 T3810 arg2Of secretion,of
R3308 T3813 T3811 arg1Of secretion,type
R3309 T3813 T3812 arg1Of secretion,III
R3310 T3815 T3814 arg1Of produced,","
R3311 T3815 T3819 arg1Of produced,compared
R3312 T3815 T3825 arg1Of produced,by
R3313 T3817 T3816 arg1Of less,three-fold
R3314 T3818 T3815 arg2Of IL-1β,produced
R3315 T3818 T3817 arg1Of IL-1β,less
R3316 T3820 T3819 arg2Of to,compared
R3317 T3824 T3820 arg2Of strain,to
R3318 T3824 T3821 arg1Of strain,the
R3319 T3824 T3822 arg1Of strain,parental
R3320 T3824 T3823 arg1Of strain,PAO1
R3321 T3827 T3825 arg2Of hours,by
R3322 T3827 T3826 arg1Of hours,24
R3323 T3827 T3828 arg1Of hours,(
R3324 T3830 T3828 arg2Of 5a,(
R3325 T3830 T3829 arg1Of 5a,Fig.
R3326 T3831 T3828 arg3Of ),(
R3327 T3833 T3832 arg1Of stimulation,Inflammasome
R3328 T3833 T3834 arg1Of stimulation,without
R3329 T3833 T3836 arg1Of stimulation,did
R3330 T3833 T3838 arg1Of stimulation,result
R3331 T3835 T3834 arg2Of priming,without
R3332 T3838 T3836 arg2Of result,did
R3333 T3838 T3837 arg1Of result,not
R3334 T3838 T3839 arg1Of result,in
R3335 T3842 T3839 arg2Of production,in
R3336 T3842 T3840 arg1Of production,any
R3337 T3842 T3841 arg1Of production,IL-1β
R3338 T3842 T3843 arg1Of production,in
R3339 T3845 T3846 arg1Of CF,or
R3340 T3846 T3843 arg2Of or,in
R3341 T3846 T3844 arg1Of or,either
R3342 T3848 T3846 arg2Of PBMCs,or
R3343 T3848 T3847 arg1Of PBMCs,control
R3344 T3849 T3850 arg1Of Contrary,to
R3345 T3852 T3850 arg2Of hypothesis,to
R3346 T3852 T3851 arg1Of hypothesis,our
R3347 T3855 T3854 arg1Of results,these
R3348 T3855 T3856 arg1Of results,indicate
R3349 T3856 T3849 arg1Of indicate,Contrary
R3350 T3856 T3853 arg1Of indicate,","
R3351 T3858 T3859 arg1Of PBMCs,from
R3352 T3858 T3862 arg1Of PBMCs,do
R3353 T3858 T3864 arg1Of PBMCs,display
R3354 T3861 T3859 arg2Of patients,from
R3355 T3861 T3860 arg1Of patients,CF
R3356 T3864 T3862 arg2Of display,do
R3357 T3864 T3863 arg1Of display,not
R3358 T3864 T3874 arg1Of display,nor
R3359 T3866 T3864 arg2Of production,display
R3360 T3866 T3865 arg2Of production,increased
R3361 T3866 T3867 arg1Of production,of
R3362 T3866 T3871 arg1Of production,with
R3363 T3868 T3869 arg1Of IL-1β,or
R3364 T3869 T3867 arg2Of or,of
R3365 T3870 T3869 arg2Of IL-8,or
R3366 T3873 T3871 arg2Of activation,with
R3367 T3873 T3872 arg1Of activation,inflammasome
R3368 T3874 T3857 arg1Of nor,that
R3369 T3874 T3877 arg1Of nor,suggest
R3370 T3875 T3874 arg2Of do,nor
R3371 T3876 T3875 arg1Of they,do
R3372 T3877 T3856 arg2Of suggest,indicate
R3373 T3880 T3881 arg1Of basal,or
R3374 T3880 T3882 arg2Of basal,induced
R3375 T3884 T3877 arg2Of activity,suggest
R3376 T3884 T3878 arg1Of activity,any
R3377 T3884 T3879 arg2Of activity,increased
R3378 T3884 T3880 arg1Of activity,basal
R3379 T3884 T3883 arg1Of activity,NF-κB
R3380 T3886 T3885 arg1Of results,These
R3381 T3886 T3887 arg1Of results,are
R3382 T3886 T3888 arg1Of results,consistent
R3383 T3888 T3887 arg2Of consistent,are
R3384 T3888 T3889 arg1Of consistent,with
R3385 T3891 T3889 arg2Of observation,with
R3386 T3891 T3890 arg1Of observation,our
R3387 T3894 T3893 arg1Of activity,caspase-1
R3388 T3894 T3895 arg1Of activity,is
R3389 T3894 T3897 arg1Of activity,different
R3390 T3895 T3891 arg2Of is,observation
R3391 T3895 T3892 arg1Of is,that
R3392 T3895 T3896 arg1Of is,not
R3393 T3897 T3895 arg2Of different,is
R3394 T3897 T3898 arg1Of different,between
R3395 T3899 T3900 arg1Of CF,and
R3396 T3901 T3900 arg2Of control,and
R3397 T3902 T3898 arg2Of PBMCs,between
R3398 T3902 T3899 arg1Of PBMCs,CF
R3399 T3902 T3901 arg1Of PBMCs,control
R3400 T3902 T3903 arg1Of PBMCs,(
R3401 T3904 T3903 arg2Of Fig.,(
R3402 T3904 T3905 arg1Of Fig.,4
R3403 T3906 T3903 arg3Of ),(
R12104 T13645 T13651 arg1Of PBMCs,produce
R12105 T13645 T13646 arg1Of PBMCs,from
R12106 T13645 T13649 arg1Of PBMCs,do
R12107 T13648 T13646 arg2Of patients,from
R12108 T13648 T13647 arg1Of patients,CF
R12109 T13651 T13650 arg1Of produce,not
R12110 T13651 T13649 arg2Of produce,do
R12111 T13653 T13651 arg2Of amounts,produce
R12112 T13653 T13652 arg2Of amounts,increased
R12113 T13653 T13654 arg1Of amounts,of
R12114 T13655 T13654 arg2Of IL-1β,of
R12115 T13656 T13657 arg1Of PBMCs,from
R12116 T13656 T13703 arg1Of PBMCs,or
R12117 T13658 T13669 modOf CF,were
R12118 T13659 T13660 arg1Of patients,(
R12119 T13659 T13663 arg1Of patients,and
R12120 T13661 T13660 arg2Of n = 17–20,(
R12121 T13662 T13660 arg3Of ),(
R12122 T13663 T13669 arg1Of and,were
R12123 T13663 T13670 arg2Of and,primed
R12124 T13665 T13663 arg2Of controls,and
R12125 T13665 T13664 arg1Of controls,healthy
R12126 T13665 T13666 arg1Of controls,(
R12127 T13667 T13666 arg2Of n = 15–19,(
R12128 T13668 T13666 arg3Of ),(
R12129 T13670 T13669 arg2Of primed,were
R12130 T13670 T13671 arg1Of primed,with
R12131 T13672 T13671 arg2Of LPS,with
R12132 T13672 T13673 arg1Of LPS,(
R12133 T13675 T13673 arg2Of ng/ml,(
R12134 T13675 T13674 arg1Of ng/ml,10
R12135 T13676 T13673 arg3Of ),(
R12136 T13677 T13678 arg1Of overnight,and
R12137 T13678 T13687 arg1Of and,","
R12138 T13679 T13678 arg2Of stimulated,and
R12139 T13679 T13680 arg1Of stimulated,with
R12140 T13683 T13680 arg2Of PAO1,with
R12141 T13683 T13681 arg1Of PAO1,P.
R12142 T13683 T13682 arg1Of PAO1,aeruginosa
R12143 T13683 T13684 arg1Of PAO1,(
R12144 T13685 T13684 arg2Of MOI = 1,(
R12145 T13686 T13684 arg3Of ),(
R12146 T13690 T13658 arg1Of PAO1,CF
R12147 T13690 T13677 arg1Of PAO1,overnight
R12148 T13690 T13679 arg2Of PAO1,stimulated
R12149 T13690 T13688 arg1Of PAO1,P.
R12150 T13690 T13689 arg1Of PAO1,aeruginosa
R12151 T13690 T13691 arg1Of PAO1,lacking
R12152 T13690 T13696 arg1Of PAO1,","
R12153 T13692 T13691 arg2Of exsA,lacking
R12154 T13692 T13693 arg1Of exsA,(
R12155 T13694 T13693 arg2Of MOI = 1,(
R12156 T13695 T13693 arg3Of ),(
R12157 T13696 T13657 arg2Of ",",from
R12158 T13697 T13696 arg2Of ATP,","
R12159 T13697 T13698 arg1Of ATP,(
R12160 T13700 T13698 arg2Of mM,(
R12161 T13700 T13699 arg1Of mM,5
R12162 T13701 T13698 arg3Of ),(
R12163 T13703 T13702 arg1Of or,","
R12164 T13703 T13714 arg1Of or,for
R12165 T13704 T13703 arg2Of Poly,or
R12166 T13704 T13705 arg1Of Poly,(
R12167 T13704 T13710 arg1Of Poly,(
R12168 T13706 T13705 arg2Of dA,(
R12169 T13706 T13707 arg1Of dA,:
R12170 T13706 T13708 arg1Of dA,dT
R12171 T13709 T13705 arg3Of ),(
R12172 T13712 T13710 arg2Of µg/ml,(
R12173 T13712 T13711 arg1Of µg/ml,1
R12174 T13713 T13710 arg3Of ),(
R12175 T13716 T13714 arg2Of hours,for
R12176 T13716 T13715 arg1Of hours,24
R12177 T13718 T13717 arg1Of aeruginosa,P.
R12178 T13718 T13719 arg1Of aeruginosa,lacking
R12179 T13718 T13721 arg1Of aeruginosa,was
R12180 T13718 T13722 arg2Of aeruginosa,used
R12181 T13720 T13719 arg2Of exsA,lacking
R12182 T13722 T13721 arg2Of used,was
R12183 T13722 T13723 arg1Of used,as
R12184 T13722 T13729 arg1Of used,in
R12185 T13728 T13723 arg2Of control,as
R12186 T13728 T13724 arg1Of control,a
R12187 T13728 T13725 arg1Of control,type
R12188 T13728 T13726 arg1Of control,III
R12189 T13728 T13727 arg1Of control,secretion
R12190 T13730 T13729 arg2Of comparison,in
R12191 T13730 T13731 arg1Of comparison,with
R12192 T13734 T13731 arg2Of aeruginosa,with
R12193 T13734 T13732 arg1Of aeruginosa,wild-type
R12194 T13734 T13733 arg1Of aeruginosa,P.
R12195 T13735 T13736 arg1Of Supernatants,were
R12196 T13735 T13737 arg2Of Supernatants,assayed
R12197 T13737 T13736 arg2Of assayed,were
R12198 T13737 T13738 arg1Of assayed,for
R12199 T13740 T13739 arg2Of A,(
R12200 T13741 T13739 arg3Of ),(
R12201 T13742 T13739 arg1Of IL-1β,(
R12202 T13742 T13743 arg1Of IL-1β,and
R12203 T13743 T13738 arg2Of and,for
R12204 T13745 T13744 arg2Of B,(
R12205 T13746 T13744 arg3Of ),(
R12206 T13747 T13743 arg2Of IL-8,and
R12207 T13747 T13744 arg1Of IL-8,(

sentences

Id Subject Object Predicate Lexical cue
T3629 0-94 Sentence denotes PBMCs from CF patients do not produce increased amounts of IL-1β upon inflammasome stimulation
T3630 95-248 Sentence denotes Previous studies have shown that the loss of CFTR results in increased NF-κB activity and pro-inflammatory cytokine secretion [4], [5], [32], [36], [37].
T3631 249-461 Sentence denotes To further examine this relationship, PBMCs from CF patients and healthy adult controls were stimulated with PAO1, LPS+ATP, and LPS+Poly(dA:dT), to activate the NLRC4, NLRP3, and AIM2 inflammasomes, respectively.
T3632 462-604 Sentence denotes By 24 hours of stimulation, CF PBMCs did not produce increased amounts of IL-1β (Fig. 5a) or IL-8 (Fig. 5b) when compared to healthy controls.
T3633 605-754 Sentence denotes However, we did notice a transient decrease (P<0.001) in the amount of IL-1β produced by CF cells in response to LPS+ATP at 6 hours (data not shown).
T3634 755-953 Sentence denotes Stimulation of PBMCs with P. aeruginosa that lacks exsA (PAO1ΔexsA), a key regulator of type III secretion, produced three-fold less IL-1β compared to the parental PAO1 strain by 24 hours (Fig. 5a).
T3635 954-1064 Sentence denotes Inflammasome stimulation without priming did not result in any IL-1β production in either CF or control PBMCs.
T3636 1065-1292 Sentence denotes Contrary to our hypothesis, these results indicate that PBMCs from CF patients do not display increased production of IL-1β or IL-8 with inflammasome activation nor do they suggest any increased basal or induced NF-κB activity.
T3637 1293-1422 Sentence denotes These results are consistent with our observation that caspase-1 activity is not different between CF and control PBMCs (Fig. 4).
T13641 1467-1532 Sentence denotes PBMCs from CF patients do not produce increased amounts of IL-1β.
T13642 1533-1786 Sentence denotes PBMCs from CF patients (n = 17–20) and healthy controls (n = 15–19) were primed with LPS (10 ng/ml) overnight and stimulated with P. aeruginosa PAO1 (MOI = 1), P. aeruginosa PAO1 lacking exsA (MOI = 1), ATP (5 mM), or Poly(dA:dT) (1 µg/ml) for 24 hours.
T13643 1787-1898 Sentence denotes P. aeruginosa lacking exsA was used as a type III secretion control in comparison with wild-type P. aeruginosa.
T13644 1899-1952 Sentence denotes Supernatants were assayed for (A) IL-1β and (B) IL-8.
T76 0-94 Sentence denotes PBMCs from CF patients do not produce increased amounts of IL-1β upon inflammasome stimulation
T77 95-248 Sentence denotes Previous studies have shown that the loss of CFTR results in increased NF-κB activity and pro-inflammatory cytokine secretion [4], [5], [32], [36], [37].
T78 249-461 Sentence denotes To further examine this relationship, PBMCs from CF patients and healthy adult controls were stimulated with PAO1, LPS+ATP, and LPS+Poly(dA:dT), to activate the NLRC4, NLRP3, and AIM2 inflammasomes, respectively.
T79 462-604 Sentence denotes By 24 hours of stimulation, CF PBMCs did not produce increased amounts of IL-1β (Fig. 5a) or IL-8 (Fig. 5b) when compared to healthy controls.
T80 605-754 Sentence denotes However, we did notice a transient decrease (P<0.001) in the amount of IL-1β produced by CF cells in response to LPS+ATP at 6 hours (data not shown).
T81 755-953 Sentence denotes Stimulation of PBMCs with P. aeruginosa that lacks exsA (PAO1ΔexsA), a key regulator of type III secretion, produced three-fold less IL-1β compared to the parental PAO1 strain by 24 hours (Fig. 5a).
T82 954-1064 Sentence denotes Inflammasome stimulation without priming did not result in any IL-1β production in either CF or control PBMCs.
T83 1065-1292 Sentence denotes Contrary to our hypothesis, these results indicate that PBMCs from CF patients do not display increased production of IL-1β or IL-8 with inflammasome activation nor do they suggest any increased basal or induced NF-κB activity.
T84 1293-1422 Sentence denotes These results are consistent with our observation that caspase-1 activity is not different between CF and control PBMCs (Fig. 4).
T85 1423-1532 Sentence denotes 10.1371/journal.pone.0037689.g005 Figure 5 PBMCs from CF patients do not produce increased amounts of IL-1β.
T86 1533-1786 Sentence denotes PBMCs from CF patients (n = 17–20) and healthy controls (n = 15–19) were primed with LPS (10 ng/ml) overnight and stimulated with P. aeruginosa PAO1 (MOI = 1), P. aeruginosa PAO1 lacking exsA (MOI = 1), ATP (5 mM), or Poly(dA:dT) (1 µg/ml) for 24 hours.
T87 1787-1898 Sentence denotes P. aeruginosa lacking exsA was used as a type III secretion control in comparison with wild-type P. aeruginosa.
T88 1899-1952 Sentence denotes Supernatants were assayed for (A) IL-1β and (B) IL-8.

2_test

Id Subject Object Predicate Lexical cue
22649552-10970832-88306709 222-223 10970832 denotes 4
22649552-11404248-88306710 227-228 11404248 denotes 5
22649552-20543983-88306711 232-234 20543983 denotes 32
22649552-19247502-88306712 238-240 19247502 denotes 36
22649552-20644644-88306713 244-246 20644644 denotes 37
T35806 222-223 10970832 denotes 4
T78747 227-228 11404248 denotes 5
T26859 232-234 20543983 denotes 32
T18939 238-240 19247502 denotes 36
T3744 244-246 20644644 denotes 37